TIMP2 and plasma cell myeloma: To investigate the association between PVR expression, serum amylase, IGFBP-7, and TIMP-2 with the survival outcomes of multiple myeloma (MM) patients, we analyzed the overall survival (OS) and progression-free survival (PFS) in relation to PVR expression status (Tables 4, 5).